Uniqure NV Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Uniqure NV Stock Summary

Uniqure NV competes with Rocket Pharmaceuticals, Rhythm Pharmaceuticals, Solid Biosciences, MeiraGTx Holdings, and Terns Pharmaceuticals. uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. The company also engages in developing AMT-130, a gene therapy that is in Phase III clinical study for the treatment of Huntingtons disease AMT-060, which is in Phase III clinical trial for the treatment of hemophilia B AMT-210, a product candidate for the treatment of Parkinsons disease AMT-260 for temporal lobe epilepsy AMT-240, a preclinical product candidate for the treatment of autosomal dominant Alzheimers disease and AMT-161 for the treatment of amyotrophic lateral sclerosis. uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands. Uniqure NV is traded on NASDAQ Exchange in the United States.

Uniqure NV Key Financial Ratios

Uniqure NV Key Balance Sheet Accounts

Uniqure NV Key Income Statement Accounts

Uniqure NV Key Cash Accounts

Uniqure Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Uniqure NV's current stock value. Our valuation model uses many indicators to compare Uniqure NV value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Uniqure NV competition to find correlations between indicators driving Uniqure NV's intrinsic value. More Info.Uniqure NV is rated below average in return on equity category among its peers. It is rated fifth in return on asset category among its peers . At present, Uniqure NV's Return On Equity is projected to drop based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Uniqure NV by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Uniqure NV Systematic Risk

Today, most investors in Uniqure NV Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Uniqure NV's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Uniqure NV growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Uniqure NV help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Uniqure NV. We use our internally-developed statistical techniques to arrive at the intrinsic value of Uniqure NV based on widely used predictive technical indicators. In general, we focus on analyzing Uniqure Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Uniqure NV's daily price indicators and compare them against related drivers.

When running Uniqure NV's price analysis, check to measure Uniqure NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Uniqure NV is operating at the current time. Most of Uniqure NV's value examination focuses on studying past and present price action to predict the probability of Uniqure NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Uniqure NV's price. Additionally, you may evaluate how the addition of Uniqure NV to your portfolios can decrease your overall portfolio volatility.